You Shuai

898 total citations
24 papers, 593 citations indexed

About

You Shuai is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, You Shuai has authored 24 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 13 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in You Shuai's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Circular RNAs in diseases (5 papers). You Shuai is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Circular RNAs in diseases (5 papers). You Shuai collaborates with scholars based in China, United States and Ethiopia. You Shuai's co-authors include Zhonghua Ma, Yongqian Shu, Tongpeng Xu, Jiafu Ji, Xiangyu Gao, Tao Yu, Wenyu Wang, Pei Ma, Rui Xia and Yanfen Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

You Shuai

20 papers receiving 592 citations

Peers

You Shuai
Xinchao Wu China
Xiao Xie China
Yuandong Liao China
Markéta Bednaříková Czechia
Zhiqi Yao China
Junqing Hou China
Liang Shao China
Haiyan Piao China
Xinchao Wu China
You Shuai
Citations per year, relative to You Shuai You Shuai (= 1×) peers Xinchao Wu

Countries citing papers authored by You Shuai

Since Specialization
Citations

This map shows the geographic impact of You Shuai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by You Shuai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites You Shuai more than expected).

Fields of papers citing papers by You Shuai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by You Shuai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by You Shuai. The network helps show where You Shuai may publish in the future.

Co-authorship network of co-authors of You Shuai

This figure shows the co-authorship network connecting the top 25 collaborators of You Shuai. A scholar is included among the top collaborators of You Shuai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with You Shuai. You Shuai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shuai, You, Zhonghua Ma, Jian Yue, et al.. (2025). MNX1-AS1 suppresses chemosensitivity by activating the PI3K/AKT pathway in breast cancer. International Journal of Biological Sciences. 21(8). 3689–3704. 1 indexed citations
2.
Liu, Jinsong, Jie Ju, Zixuan Yang, et al.. (2025). Genetic associations of plasma proteins and breast cancer identify potential therapeutic drug candidates. Communications Biology. 8(1). 610–610.
3.
Shuai, You, Zhonghua Ma, & Peng Yuan. (2024). Disulfidptosis: disulfide stress‐induced novel cell death pathway. SHILAP Revista de lepidopterología. 5(7). e579–e579. 3 indexed citations
4.
Shuai, You, Zhonghua Ma, Jie Ju, et al.. (2024). The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD. APOPTOSIS. 30(1-2). 226–238. 3 indexed citations
5.
6.
Liu, Jinsong, Fan Yang, Zixuan Yang, et al.. (2024). Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization. Human Vaccines & Immunotherapeutics. 20(1). 2410557–2410557. 2 indexed citations
7.
8.
Wei, Tong, Songlin Gao, Xue Wang, et al.. (2023). Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis. Frontiers in Oncology. 13. 1100332–1100332. 9 indexed citations
9.
Shuai, You, Zhonghua Ma, Jie Ju, et al.. (2023). Liquid-based biomarkers in breast cancer: looking beyond the blood. Journal of Translational Medicine. 21(1). 809–809. 14 indexed citations
10.
11.
Cheng, Lingling, Kang Li, You Shuai, et al.. (2021). Correlation between L3 skeletal muscle index and prognosis of patients with stage IV gastric cancer. Journal of Gastrointestinal Oncology. 12(5). 2073–2081. 10 indexed citations
12.
Wei, Qiang, Lingxiang Chen, You Shuai, et al.. (2021). Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer. Journal of Gastrointestinal Oncology. 12(6). 2775–2787. 4 indexed citations
13.
Ma, Zhonghua, You Shuai, Xiangyu Gao, Xianzi Wen, & Jiafu Ji. (2020). Circular RNAs in the tumour microenvironment. Molecular Cancer. 19(1). 8–8. 72 indexed citations
14.
Yan, Yu, et al.. (2020). Long Non-Coding RNA MALAT1 as a Detection and Diagnostic Molecular Marker in Various Human Cancers: A Pooled Analysis Based on 3255 Subjects. SHILAP Revista de lepidopterología.
15.
Shuai, You, Zhonghua Ma, Weitao Liu, et al.. (2020). TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Molecular Cancer. 19(1). 6–6. 105 indexed citations
16.
Ma, Zhonghua, You Shuai, Xiangyu Gao, et al.. (2020). BTEB2-Activated lncRNA TSPEAR-AS2 Drives GC Progression through Suppressing GJA1 Expression and Upregulating CLDN4 Expression. Molecular Therapy — Nucleic Acids. 22. 1129–1141. 14 indexed citations
17.
Ma, Zhonghua, Xiangyu Gao, You Shuai, et al.. (2020). EGR1‐mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer. Cell Proliferation. 54(1). e12922–e12922. 63 indexed citations
18.
Xu, Tongpeng, Pei Ma, Wenyu Wang, et al.. (2019). KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. Cell Death and Differentiation. 26(11). 2179–2193. 73 indexed citations
19.
20.
Ma, Tianshi, Hongwei Ma, Xuezhi He, et al.. (2018). The Long Intergenic Noncoding RNA 00707 Promotes Lung Adenocarcinoma Cell Proliferation and Migration by Regulating Cdc42. Cellular Physiology and Biochemistry. 45(4). 1566–1580. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinchao Wu Breakdown of academic impact, for papers by Xiao Xie Breakdown of academic impact, for papers by Yuandong Liao Breakdown of academic impact, for papers by Markéta Bednaříková Breakdown of academic impact, for papers by Zhiqi Yao Breakdown of academic impact, for papers by Junqing Hou Breakdown of academic impact, for papers by Liang Shao Breakdown of academic impact, for papers by Haiyan Piao
Rankless by CCL
2026